{"id":"https://openalex.org/W7168758477","doi":"https://doi.org/10.5772/intechopen.1016844","title":"Antiretroviral Therapies and MASLD: Weight Gain, Insulin Resistance and Hepatic Steatosis","display_name":"Antiretroviral Therapies and MASLD: Weight Gain, Insulin Resistance and Hepatic Steatosis","publication_year":2026,"publication_date":"2026-07-15","ids":{"openalex":"https://openalex.org/W7168758477","doi":"https://doi.org/10.5772/intechopen.1016844"},"language":"en","primary_location":{"id":"doi:10.5772/intechopen.1016844","doi":"https://doi.org/10.5772/intechopen.1016844","is_oa":true,"landing_page_url":"https://doi.org/10.5772/intechopen.1016844","pdf_url":"https://www.intechopen.com/citation-pdf-url/1255559","source":{"id":"https://openalex.org/S4306463448","display_name":"IntechOpen eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310322558","host_organization_name":"IntechOpen","host_organization_lineage":["https://openalex.org/P4310322558"],"host_organization_lineage_names":["IntechOpen"],"type":"ebook platform"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Metabolic Dysfunction-Associated Steatotic Liver Disease [Working Title]","raw_type":"book-chapter"},"volume":null,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.intechopen.com/citation-pdf-url/1255559","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082107688","display_name":"\u00c7i\u011fdem Mermutluo\u011flu","orcid":"https://orcid.org/0000-0003-1836-6281","observed_orcids":["https://orcid.org/0000-0003-1836-6281"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u00c7i\u011fdem Mermutluo\u011flu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101469532","display_name":"Mustafa Kemal \u00c7elen","orcid":"https://orcid.org/0000-0002-7390-1083","observed_orcids":["https://orcid.org/0000-0002-7390-1083","https://orcid.org/0000-0001-5876-2241"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mustafa Kemal \u00c7elen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.03779999911785126,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.953000009059906},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9340000152587891},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.7200000286102295},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.8840000033378601},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.984000027179718},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/integrase-strand-transfer-inhibitors","display_name":"integrase strand transfer inhibitors","score":0.9340000152587891},{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.5709999799728394},{"id":"https://openalex.org/keywords/visceral-fat","display_name":"visceral fat","score":0.6819999814033508},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.7929999828338623},{"id":"https://openalex.org/keywords/immune-activation","display_name":"immune activation","score":0.671999990940094},{"id":"https://openalex.org/keywords/cardiometabolic-risk","display_name":"cardiometabolic risk","score":0.7120000123977661},{"id":"https://openalex.org/keywords/screening-and-monitoring","display_name":"screening and monitoring","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.828000009059906},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.7287999987602234},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.676800012588501},{"id":"https://openalex.org/C2780941825","wikidata":"https://www.wikidata.org/wiki/Q1538213","display_name":"Lipodystrophy","level":5,"score":0.5523999929428101},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.47929999232292175},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46860000491142273},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.4101000130176544},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.4088999927043915},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.3650999963283539},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.36239999532699585},{"id":"https://openalex.org/C2779889181","wikidata":"https://www.wikidata.org/wiki/Q423984","display_name":"Stavudine","level":5,"score":0.359499990940094},{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.35659998655319214},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35190001130104065},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.34040001034736633},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33709999918937683},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.329800009727478},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.3215000033378601},{"id":"https://openalex.org/C2776954865","wikidata":"https://www.wikidata.org/wiki/Q1546498","display_name":"Nonalcoholic fatty liver disease","level":4,"score":0.31279999017715454},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.30320000648498535},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.29580000042915344},{"id":"https://openalex.org/C2779546735","wikidata":"https://www.wikidata.org/wiki/Q3500973","display_name":"Lipoatrophy","level":5,"score":0.29330000281333923},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2897999882698059},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.2728999853134155},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2712000012397766},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.26080000400543213},{"id":"https://openalex.org/C133925201","wikidata":"https://www.wikidata.org/wiki/Q188419","display_name":"Life expectancy","level":3,"score":0.2565999925136566}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.5772/intechopen.1016844","doi":"https://doi.org/10.5772/intechopen.1016844","is_oa":true,"landing_page_url":"https://doi.org/10.5772/intechopen.1016844","pdf_url":"https://www.intechopen.com/citation-pdf-url/1255559","source":{"id":"https://openalex.org/S4306463448","display_name":"IntechOpen eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310322558","host_organization_name":"IntechOpen","host_organization_lineage":["https://openalex.org/P4310322558"],"host_organization_lineage_names":["IntechOpen"],"type":"ebook platform"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Metabolic Dysfunction-Associated Steatotic Liver Disease [Working Title]","raw_type":"book-chapter"}],"best_oa_location":{"id":"doi:10.5772/intechopen.1016844","doi":"https://doi.org/10.5772/intechopen.1016844","is_oa":true,"landing_page_url":"https://doi.org/10.5772/intechopen.1016844","pdf_url":"https://www.intechopen.com/citation-pdf-url/1255559","source":{"id":"https://openalex.org/S4306463448","display_name":"IntechOpen eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310322558","host_organization_name":"IntechOpen","host_organization_lineage":["https://openalex.org/P4310322558"],"host_organization_lineage_names":["IntechOpen"],"type":"ebook platform"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Metabolic Dysfunction-Associated Steatotic Liver Disease [Working Title]","raw_type":"book-chapter"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7168758477.pdf","grobid_xml":"https://content.openalex.org/works/W7168758477.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1985592156","https://openalex.org/W2062274686","https://openalex.org/W2139351004","https://openalex.org/W2162382402","https://openalex.org/W2324473093","https://openalex.org/W2589922704","https://openalex.org/W2810423511","https://openalex.org/W2810629608","https://openalex.org/W2962964639","https://openalex.org/W2979917028","https://openalex.org/W4384119924","https://openalex.org/W4385172574","https://openalex.org/W4389575526","https://openalex.org/W4390449567","https://openalex.org/W4391211869","https://openalex.org/W4394735394","https://openalex.org/W4396234476","https://openalex.org/W4399435116","https://openalex.org/W4401276730","https://openalex.org/W4404891514","https://openalex.org/W4410202668","https://openalex.org/W4415189434"],"related_works":["https://openalex.org/W4414899126","https://openalex.org/W4399514052","https://openalex.org/W4389815328","https://openalex.org/W2959078404","https://openalex.org/W4416947195","https://openalex.org/W4406336458","https://openalex.org/W4409339217","https://openalex.org/W4220857454","https://openalex.org/W7128588042","https://openalex.org/W6966953914"],"abstract_inverted_index":{"Antiretroviral":[0],"therapy":[1],"(ART)":[2],"has":[3,32],"markedly":[4],"changed":[5],"the":[6,61,86,172,184],"clinical":[7,47],"course":[8],"of":[9,63,104,150,186],"human":[10],"immunodeficiency":[11],"virus":[12],"(HIV)":[13],"infection":[14],"by":[15,97],"reducing":[16],"morbidity":[17],"and":[18,20,72,88,100,114,128,161,180,188,196],"mortality":[19],"extending":[21],"life":[22],"expectancy":[23],"in":[24,46,58,92,125,132,198],"people":[25],"living":[26],"with":[27,76,121],"HIV":[28,31],"(PLWH).":[29],"As":[30],"become":[33,43],"a":[34,101,190],"chronic":[35,70],"condition":[36],"requiring":[37],"long-term":[38],"follow-up,":[39],"non-AIDS-related":[40],"comorbidities":[41],"have":[42,118],"increasingly":[44,56],"important":[45],"care.":[48],"Metabolic":[49],"dysfunction-associated":[50,82],"steatotic":[51],"liver":[52],"disease":[53],"(MASLD)":[54],"is":[55,95,138],"recognised":[57],"PLWH":[59],"at":[60],"intersection":[62],"obesity,":[64],"visceral":[65],"adiposity,":[66],"insulin":[67,178],"resistance,":[68,179],"dyslipidaemia,":[69],"inflammation,":[71],"metabolic":[73,81,130],"changes":[74,124],"associated":[75,120],"ART.":[77,145],"Within":[78],"this":[79,136],"spectrum,":[80],"steatohepatitis":[83],"(MASH)":[84],"represents":[85],"inflammatory":[87],"potentially":[89],"progressive":[90],"phenotype,":[91],"which":[93],"steatosis":[94,182],"accompanied":[96],"hepatocellular":[98],"injury":[99],"higher":[102],"risk":[103,131],"fibrosis.":[105],"Modern":[106],"regimens":[107],"containing":[108],"integrase":[109],"strand":[110],"transfer":[111],"inhibitors":[112],"(INSTIs)":[113],"tenofovir":[115],"alafenamide":[116],"(TAF)":[117],"been":[119],"weight":[122,176],"gain,":[123,177],"fat":[126],"distribution,":[127],"increased":[129],"some":[133],"studies.":[134],"However,":[135],"relationship":[137,173],"neither":[139],"linear":[140],"nor":[141],"solely":[142],"attributable":[143],"to":[144,193],"The":[146],"rebound-to-health":[147],"phenomenon,":[148],"discontinuation":[149],"previous":[151],"weight-suppressing":[152],"antiretroviral":[153],"agents,":[154],"host-related":[155],"cardiometabolic":[156],"predisposition,":[157],"HIV-associated":[158],"immune":[159],"activation,":[160],"lifestyle":[162],"factors":[163],"should":[164],"all":[165],"be":[166],"considered":[167],"together.":[168],"This":[169],"chapter":[170],"reviews":[171],"between":[174],"ART,":[175],"hepatic":[181],"within":[183],"context":[185],"MASLD,":[187],"outlines":[189],"practical":[191],"approach":[192],"screening,":[194],"monitoring,":[195],"management":[197],"PLWH.":[199]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2026-07-17T00:00:00"}